Company Filing History:
Years Active: 2020
Title: Steve Pemberton: Innovator in Microfluidic Technology
Introduction
Steve Pemberton, an accomplished inventor based in Bedford, NH, has made significant contributions to the field of microfluidics. He holds one patent that showcases his innovative approach to dissecting and analyzing individual cell samples. His work aims to enhance the precision and efficiency of cell sampling, which is critical in various scientific and medical applications.
Latest Patents
Steve's patent is titled “Device and method for dissecting and analyzing individual cell samples.” This patent describes a method for dissecting and collecting one or more cells from a tissue sample fixed to an inner surface of a microfluidic device. The process involves fluid communication with a channel defined by the microfluidic device, where specific steps are taken to ensure the accurate collection of cells. This advancement has the potential to improve cellular analysis techniques in research and clinical settings.
Career Highlights
Steve Pemberton is an integral part of Biosyntagma, LLC, where he plays a crucial role in developing innovative solutions for cellular analysis. His expertise in microfluidic technology allows him to lead projects with a focus on precision and efficiency. With his single patent, he has established himself as a noteworthy inventor in the field.
Collaborations
Throughout his career, Steve has collaborated with notable coworkers, including David Wayne Richardson and Dmitry Derkach. Together, they contribute to the advancement of technology at Biosyntagma, LLC, driving innovations that aim to refine cellular analysis methods.
Conclusion
Steve Pemberton exemplifies the spirit of innovation through his work in microfluidics. His patent for a device and method for dissecting and analyzing individual cell samples highlights his dedication to advancing scientific research and improving cell analysis technologies. As he continues to work with his team at Biosyntagma, LLC, his contributions are expected to have a significant impact on the future of cellular research.